"These residents are the horses that make this place run, and they're not feeding them enough." -- Stuart Bussey, MD, JD, president of Union of American Physicians and Dentists, discussing the University of Buffalo striking trainees who have been in contract limbo for a year.
"The scariest part is, there's no ingredient list necessarily on the box." -- Alina Djougarian, MD, of Northwell Health in New York, warning about eye color-changing drops sold online.
"This case with Matthew Perry is kind of like a sentinel event." -- Gerald Busch, MD, MPH, of the American Psychiatric Association's Council on Addiction Psychiatry, about how the actor's death may signal a nationwide ketamine problem.
"You would be ill-advised to think that everyone isn't potentially vulnerable." -- John Lauriello, MD, of Thomas Jefferson University in Philadelphia, on tardive dyskinesia risk with dopamine receptor-blocking drugs.
"That was, to me, really like a moment of wonder." -- Amish Shah, MD, MPH, a Democrat in Arizona's state legislature, on his inspiration to pursue medicine.
"The situation is complicated by the detection of a new variant." -- Jay Varma, MD, of SIGA Technologies in New York City, discussing recent developments with the global mpox emergency.
"It really doesn't make sense." -- Shun Yu, MD, of NYU Langone Medical Center in New York City, on using bolus 5-fluorouracil with chemotherapy for gastrointestinal cancers.
"[The] science communication aspect of this musical is really unmatched." -- Judy Minkoff, PhD, of New York University Langone Health, on an off-Broadway show about antimicrobial resistance.